These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35411933)

  • 1. Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy.
    Natsui H; Konishi T; Saiin K; Tamaki Y; Sato T; Takenaka S; Tada A; Mizuguchi Y; Kobayashi Y; Sato T; Kamada R; Kamiya K; Nagai T; Tanaka S; Anzai T
    Cardiol J; 2022; 29(2):362-363. PubMed ID: 35411933
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristics of Coronary Atherosclerosis Related to Plaque Burden Regression During Treatment With Alirocumab: The ARCHITECT Study.
    Pérez de Isla L; Díaz-Díaz JL; Romero MJ; Muñiz-Grijalvo O; Mediavilla JD; Argüeso R; de Andrés R; Fuentes F; Sánchez Muñoz-Torrero JF; Rubio P; Álvarez-Baños P; Mañas D; Suárez Gutierrez L; Saltijeral Cerezo A; Mata P;
    Circ Cardiovasc Imaging; 2024 Jan; 17(1):e016206. PubMed ID: 38205656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
    Bos S; Duvekot MH; Ten Kate GR; Verhoeven AJ; Mulder MT; Schinkel AF; Nieman K; Watts GF; Sijbrands EJ; Roeters van Lennep JE
    Atherosclerosis; 2017 Jan; 256():62-66. PubMed ID: 28012444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stabilization of vulnerable coronary plaque].
    Chibana H; Mitsutake Y; Itaya N; Ueno T
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():306-10. PubMed ID: 22724220
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of alirocumab on coronary atheroma volume in Japanese patients with acute coronary syndromes and hypercholesterolemia not adequately controlled with statins: ODYSSEY J-IVUS rationale and design.
    Ako J; Hibi K; Kozuma K; Miyauchi K; Morino Y; Shinke T; Tsujita K; Uno K; Kawabata Y; Hiro T
    J Cardiol; 2018 Jun; 71(6):583-589. PubMed ID: 29606415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Miname MH; Bittencourt MS; Nasir K; Santos RD
    Curr Opin Lipidol; 2019 Apr; 30(2):82-87. PubMed ID: 30649025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Daniels SR; Gidding SS; de Ferranti SD;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S30-7. PubMed ID: 21600527
    [No Abstract]   [Full Text] [Related]  

  • 8. Current status of lipid management in acute coronary syndrome.
    Fujisue K; Tsujita K
    J Cardiol; 2017 Aug; 70(2):101-106. PubMed ID: 28325524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
    Aljenedil S; Ruel I; Watters K; Genest J
    J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too Little.
    Hovingh GK; Kastelein JJ
    Circulation; 2016 Sep; 134(10):710-2. PubMed ID: 27601557
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.
    Miyauchi K; Daida H; Morimoto T; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Kadota K; Kimura K; Hirayama A; Kimura K; Hasegawa Y; Uchiyama S; Matsuzaki M;
    Circ J; 2012; 76(4):825-32. PubMed ID: 22451449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study].
    Miyauchi K
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():321-30. PubMed ID: 22724223
    [No Abstract]   [Full Text] [Related]  

  • 14. Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia.
    Chiva-Blanch G; Padró T; Alonso R; Crespo J; Perez de Isla L; Mata P; Badimon L
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):945-955. PubMed ID: 30866660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative plaque stabilization but not quantitative plaque regression.
    Nishigaki K
    Circ J; 2012; 76(4):809-11. PubMed ID: 22451448
    [No Abstract]   [Full Text] [Related]  

  • 16. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
    Dyrbuś K; Gąsior M; Desperak P; Osadnik T; Nowak J; Banach M
    Atherosclerosis; 2019 Sep; 288():33-41. PubMed ID: 31319356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins.
    Shiomi M; Koike T; Ito T
    Atherosclerosis; 2013 Nov; 231(1):39-47. PubMed ID: 24125408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for familial hypercholesterolemia from low-density lipoprotein cholesterol levels at admission in the coronary care unit].
    Chemaly P; Nallet O; Delarche N; Legagneur C; Boulestreau R; Reibel I; Palette C; Grenier A; Courtade H; Beaune G; Belle L; Georges JL
    Ann Cardiol Angeiol (Paris); 2018 Nov; 67(5):300-309. PubMed ID: 30290906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid laden in the true sense.
    Lohiya RV; Phadke M; Lanjewar C; Kerkar P
    Eur Heart J; 2015 Jan; 36(1):49. PubMed ID: 25336218
    [No Abstract]   [Full Text] [Related]  

  • 20. [Severe coronary artery disease in premenopausal woman with familial hypercholesterolaemia].
    Roszczyk N; Wierzbowska-Drabik K; Kręcki R; Kasprzak JD
    Kardiol Pol; 2013; 71(5):505-8. PubMed ID: 23788092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.